Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Recher

Showing results (381-390 of 488) with videos related to

Pageof 49
Sort By:
Haematologica|September 22, 2011
High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) studyFrançois Vergez, Alexa S Green, Jerome Tamburini, et al.
Haematologica|December 10, 2020
Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D-NPM1 mutations by digital polymerase chain reaction: feasibility and clinical useAuriane Lesieur, Xavier Thomas, Olivier Nibourel, et al.
Emerging Infectious Diseases|September 25, 2024
Circovirus Hepatitis in Immunocompromised Patient, SwitzerlandBaptiste Hamelin, Philippe Pérot, Ian Pichler, et al.
Oncotarget|April 16, 2016
Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemiaNorbert Vey, Jacques Delaunay, Giovanni Martinelli, et al.
The Journal of Allergy and Clinical Immunology|May 17, 2011
Reduced thymic output, cell cycle abnormalities, and increased apoptosis of T lymphocytes in patients with cartilage-hair hypoplasiaMiguel A de la Fuente, Mike Recher, Nicholas L Rider, et al.
Hepatology Communications|February 15, 2022
Single MHC-I Expression Promotes Virus-Induced Liver ImmunopathologyHaifeng C Xu, Jun Huang, Aleksandra A Pandyra, et al.
American Journal of Hematology|August 23, 2012
Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS studyRomain Guièze, Pascale Cornillet-Lefebvre, Bruno Lioure, et al.
Leukemia|May 29, 2010
Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trialP Chevallier, L Fornecker, B Lioure, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in micePhilipp A Lang, Mike Recher, Nadine Honke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMSArnaud Pigneux, Jean-Luc Harousseau, Francis Witz, et al.
Pageof 49

Showing results (381-390 of 488) with videos related to

Sort By:
Pageof 49
Haematologica|September 22, 2011
High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) studyFrançois Vergez, Alexa S Green, Jerome Tamburini, et al.
Haematologica|December 10, 2020
Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D-NPM1 mutations by digital polymerase chain reaction: feasibility and clinical useAuriane Lesieur, Xavier Thomas, Olivier Nibourel, et al.
Emerging Infectious Diseases|September 25, 2024
Circovirus Hepatitis in Immunocompromised Patient, SwitzerlandBaptiste Hamelin, Philippe Pérot, Ian Pichler, et al.
Oncotarget|April 16, 2016
Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemiaNorbert Vey, Jacques Delaunay, Giovanni Martinelli, et al.
The Journal of Allergy and Clinical Immunology|May 17, 2011
Reduced thymic output, cell cycle abnormalities, and increased apoptosis of T lymphocytes in patients with cartilage-hair hypoplasiaMiguel A de la Fuente, Mike Recher, Nicholas L Rider, et al.
Hepatology Communications|February 15, 2022
Single MHC-I Expression Promotes Virus-Induced Liver ImmunopathologyHaifeng C Xu, Jun Huang, Aleksandra A Pandyra, et al.
American Journal of Hematology|August 23, 2012
Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS studyRomain Guièze, Pascale Cornillet-Lefebvre, Bruno Lioure, et al.
Leukemia|May 29, 2010
Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trialP Chevallier, L Fornecker, B Lioure, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in micePhilipp A Lang, Mike Recher, Nadine Honke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMSArnaud Pigneux, Jean-Luc Harousseau, Francis Witz, et al.
Pageof 49